FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months

FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...
Le Lézard

Precision Biotics Market worth $9.26 billion by 2031- Exclusive Report by MarketsandMarketstm

According to MarketsandMarketstm, the precision biotics market is projected to grow from USD 4.91 billion in 2026 and to reach USD 9.26 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 13.5 ...
The Tech Edvocate

Staggering: Best CD Rates 2026 Are Challenging Everything You Thought About Savings

Spread the love“`html As we step into July 2026, the financial landscape is buzzing with excitement, especially for those ...
DPA Magazine

binder prints electronics directly onto the component

At the binder Innovation and Technology Center (ITZ), sensors, heating elements and conductor tracks are produced by printing ...
Le Lézard

Lantern Pharma Launches ZetaOmicstm ? an Autonomous, Intelligent "Computational Biologist" That Brings Expert-Grade Bioinformatics, Biostatistics & Reasoning to Every Cancer

Lantern Pharma Inc. , a clinical-stage, AI-driven precision oncology company, today announced the launch of ZetaOmics, the computational-biology module of its multi-agentic AI co-scientist platform, ...